Cite
A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018
MLA
Viprey, Virginie F., et al. “A Point-Prevalence Study on Community and Inpatient Clostridioides Difficile Infections (CDI): Results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018.” Eurosurveillance, vol. 27, June 2022. EBSCOhost, https://doi.org/10.2807/1560-7917.es.2022.27.26.2100704.
APA
Viprey, V. F., Davis, G. L., Benson, A. D., Ewin, D., Spittal, W., Vernon, J. J., Rupnik, M., Banz, A., Allantaz, F., Cleuziat, P., Novakova, E., Matussek, A. A., Fitzpatrick, F., Simon, A., Macovei, I., Barbut, F., Ramirez, E. R., Petinaki, E., Kuijper, E. J., … Davies, K. A. (2022). A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018. Eurosurveillance, 27. https://doi.org/10.2807/1560-7917.es.2022.27.26.2100704
Chicago
Viprey, Virginie F., Georgina L. Davis, Anthony D. Benson, Duncan Ewin, William Spittal, Jon J. Vernon, Maja Rupnik, et al. 2022. “A Point-Prevalence Study on Community and Inpatient Clostridioides Difficile Infections (CDI): Results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018.” Eurosurveillance 27 (June). doi:10.2807/1560-7917.es.2022.27.26.2100704.